Geron Corp.

A lagger security in the Health Care that looks (login to see)

Yahoo! Profile

GERN

Biotechnology
Weighting

Weak Growth

Lead | Lag

Bottom Growth

Options

n/a

P/E Ratio

13.37

Free Cash Flow

Poor (-308.18)

Dividend

none

Begin Today!

Have access to custom plans you can create, auto-portfolios and much more!




NO OBLIGATION TO BUY